REFERENCES
- Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: Systematic review and meta-analysis. BMJ 2007; 335(7627):974.
- Nisell H, Lintu H, Lunell NO, Mollerstrom G, Pettersson E. Blood pressure and renal function seven years after pregnancy complicated by hypertension. Br J Obstet Gynaecol 1995; 102(11):876–881.
- Kist WJ, Janssen NG, Kalk JJ, Hague WM, Dekker GA, de Vries JI. Thrombophilias and adverse pregnancy outcome – A confounded problem! Thromb Haemost 2008; 99(1):77–85.
- Kupferminc MJ, Rimon E, Ascher-Landsberg J, Lessing JB, Many A. Perinatal outcome in women with severe pregnancy complications and multiple thrombophilias. J Perinat Med 2004; 32(3):225–227.
- Rosendaal FR, Siscovick DS, Schwartz SM, Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood 1997; 89(8):2817–2821.
- Doggen CJ, Cats VM, Bertina RM, Rosendaal FR. Interaction of coagulation defects and cardiovascular risk factors: Increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A. Circulation 1998; 97(11):1037–1041.
- Evans SM, Brittenden J, Adam DJ, Ludlam C, Bradbury AW. Vascular surgical society of great britain and ireland: Prevalence and significance of thrombophilia in patients with intermittent claudication. Br J Surg 1999; 86(5):702–703.
- Serne EH, Stehouwer CD, ter Maaten JC, Microvascular function relates to insulin sensitivity and blood pressure in normal subjects. Circulation 1999; 99(7):896–902.
- Serne EH, de Jongh RT, Eringa EC, Ijzerman RG, Stehouwer CD. Microvascular dysfunction: A potential pathophysiological role in the metabolic syndrome. Hypertension 2007; 50(1):204–211.
- Ijzerman RG, de Jongh RT, Beijk MA, Individuals at increased coronary heart disease risk are characterized by an impaired microvascular function in skin. Eur J Clin Invest 2003; 33(7):536–542.
- Ramsay JE, Stewart F, Greer IA, Sattar N. Microvascular dysfunction: A link between pre-eclampsia and maternal coronary heart disease. BJOG 2003; 110(11):1029–1031.
- Ijzerman RG, van Weissenbruch MM, Voordouw JJ, The association between birth weight and capillary recruitment is independent of blood pressure and insulin sensitivity: A study in prepubertal children. J Hypertens 2002; 20(10):1957–1963.
- Wolf M, Sandler L, Munoz K, Hsu K, Ecker JL, Thadhani R. First trimester insulin resistance and subsequent preeclampsia: A prospective study. J Clin Endocrinol Metab 2002; 87(4):1563–1568.
- Catalano PM, Drago NM, Amini SB. Maternal carbohydrate metabolism and its relationship to fetal growth and body composition. Am J Obstet Gynecol 1995; 172(5):1464–1470.
- Dekker GA, de Vries JI, Doelitzsch PM, Underlying disorders associated with severe early-onset pre-eclampsia. Am J Obstet Gynecol 1995; 173(4):1042–1048.
- National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 1990; 163(5 Pt 1):1691–1712.
- Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988; 158(4):892–898.
- Caritis S, Sibai B, Hauth J, Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998; 338(11):701–705.
- Bakketeig LS. Current growth standards, definitions, diagnosis and classification of fetal growth retardation. Eur J Clin Nutr 1998; 52(Suppl. 1):S1–S4.
- Twisk JW, Kemper HC, van MW, Post GB, van Lenthe FJ. Body fatness: Longitudinal relationship of body mass index and the sum of skinfolds with other risk factors for coronary heart disease. Int J Obes Relat Metab Disord 1998; 22(9):915–922.
- Fox K, Peters D, Armstrong N, Sharpe P, Bell M. Abdominal fat deposition in 11-year-old children. Int J Obes Relat Metab Disord 1993; 17(1):11–16.
- van Guldener C, Janssen MJ, Lambert J, Steyn M, Donker AJ, Stehouwer CD. Endothelium-dependent vasodilatation is impaired in peritoneal dialysis patients. Nephrol Dial Transplant 1998; 13(7):1782–1786.
- McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/eclampsia: A systematic review and meta-analyses. Am Heart J 2008; 156(5):918–930.
- Grundy SM, Brewer HB, Jr., Cleeman JI, Smith SC, Jr., Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109(3):433–438.
- Soonthornpun K, Soonthornpun S, Wannaro P, Setasuban W, Thamprasit A. Insulin resistance in women with a history of severe pre-eclampsia. J Obstet Gynaecol Res 2009; 35(1):55–59.
- Fuh MM, Yin CS, Pei D, Resistance to insulin-mediated glucose uptake and hyperinsulinemia in women who had preeclampsia during pregnancy. Am J Hypertens 1995; 8(7):768–771.
- Henry RM, Kostense PJ, Spijkerman AM, Arterial stiffness increases with deteriorating glucose tolerance status: The Hoorn study. Circulation 2003; 107(16):2089–2095.
- Levitzky YS, Pencina MJ, D'Agostino RB, Impact of impaired fasting glucose on cardiovascular disease: The Framingham heart study. J Am Coll Cardiol 2008; 51(3):264–270.
- Blaauw J, Graaff R, van Pampus MG, Abnormal endothelium-dependent microvascular reactivity in recently preeclamptic women. Obstet Gynecol 2005; 105(3):626–632.
- Schobel HP, Fischer T, Heuszer K, Geiger H, Schmieder RE. Preeclampsia – A state of sympathetic overactivity. N Engl J Med 1996; 335(20):1480–1485.
- Sipila K, Moilanen L, Nieminen T, Metabolic syndrome and carotid intima media thickness in the Health 2000 Survey. Atherosclerosis 2009; 204(1):276–281.
- Berends AL, de Groot CJ, Sijbrands EJ, Shared constitutional risks for maternal vascular-related pregnancy complications and future cardiovascular disease. Hypertension 2008; 51(4):1034–1041.
- Segev A, Ellis MH, Segev F, High prevalence of thrombophilia among young patients with myocardial infarction and few conventional risk factors. Int J Cardiol 2005; 98(3):421–424.
- Spaanderman ME, Ekhart TH, van EJ, Cheriex EC, de Leeuw PW, Peeters LL. Latent hemodynamic abnormalities in symptom-free women with a history of preeclampsia. Am J Obstet Gynecol 2000; 182(1 Pt 1):101–107.
- Barden AE, Beilin LJ, Ritchie J, Walters BN, Michael C. Does a predisposition to the metabolic syndrome sensitize women to develop pre-eclampsia? J Hypertens 1999; 17(9):1307–1315.
- Brenner B, Aharon A. Thrombophilia and adverse pregnancy outcome. Clin Perinatol 2007; 34(4):527–541, v.
- Goswami D, Tannetta DS, Magee LA, Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta 2006; 27(1):56–61.
- Franchi F, Biguzzi E, Cetin I, Mutations in the thrombomodulin and endothelial protein C receptor genes in women with late fetal loss. Br J Haematol 2001; 114(3):641–646.
- Ames PR, Antinolfi I, Scenna G, Gaeta G, Margaglione M, Margarita A. Atherosclerosis in thrombotic primary antiphospholipid syndrome. J Thromb Haemost 2009; 7(4):537–542.
- Sacks GP, Studena K, Sargent K, Redman CW. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 1998; 179(1):80–86.